• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS RUB IGG II 60 TESTS; VIDAS RUB IGG II 60 TESTS - 30221

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS RUB IGG II 60 TESTS; VIDAS RUB IGG II 60 TESTS - 30221 Back to Search Results
Catalog Number 30221
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer from (b)(6) reported to biomérieux that they observed a false positive result for a patient tested with vidas rub igg ii 60 tests (ref.30221, lot 1007673260, expiry date = 10-oct-2020).The concerned patient is a pregnant woman, who gave birth on 03-mar-2020.It is reported that this patient did not have neither vaccination, neither gamma-globulin injection.The customer obtained the following results for this patient with vidas rub igg ii 60 tests, lot 1007673260.Test performed on (b)(6) 2020 for a first sample collected before delivery (sample 1): negative.Test performed on (b)(6) 2020 for a second sample collected on (b)(6) 2020 (sample 2): result = 59 iu / ml (positive).Re-tests of both samples performed on (b)(6) 2020: results = 9 iu / ml and 8 iu / ml (negative).Re-test of sample 2 on (b)(6) 2020: result = 7 iu / ml (negative).There is no indication or report from the laboratory that the false positive result led to any adverse event related to the patient's state of health.Ref 30221 is not registered with the fda for use in the united states.According to trackit, the registration status for ref 30221 is "on hold." however, a similar product, ref 30226, is registered with the fda for use in the united states (k141133).A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An investigation was initiated in response to a customer complaint of a false positive result for a patient tested with vidas rub igg ii 60 tests (ref.30221, lot 1007673260, expiry date = 10-oct-2020).The complaints laboratory performed a historical review of complaint records for the period between the 19mar2019 and the 28may2020.The review identified one (1) other complaint for false positive result, but the cause for the false positive result was the presence of an interference.The analysis of vidas rub igg ii lot 1007673260 /201010-0 showed no anomaly during the manufacturing, control and packaging processes.The instrument logs and one (1) sample (512200650166) were received from the customer for investigational purposes.Control chart analysis: this analysis was performed with four (4) internal negative samples on five (5) vidas® rub igg ii lots, including the customer's lot (1007673260 /201010-0).All samples tested on all lots obtained negative results and the customer's lot was in trend with the other lots.Customer sample: the customer's sample was tested with a retain sample of the customer's lot (1007673260 /201010-0).Analysis was performed on a vidas® 3 instrument twice and on a vidas® pc instrument twice.Negative results were obtained three (3) times and an equivocal result was obtained one (1) time.The variability observed during these tests is in accordance with expected variation for negative results.The customer's false positive result was not reproduced internally.Analysis performed by the system engineering and support department: the instrument logs collected on the customer¿s vidas®3 instrument were analyzed internally and did not highlight any anomalies.Conclusion: the customer's false positive result was not reproduced internally.According to the analysis performed on the instrument logs, there was no anomaly identified that could cause the false positive result.A potential cause for the false positive result observed by the customer is the presence of interference in the sample that has dissipated over time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS RUB IGG II 60 TESTS
Type of Device
VIDAS RUB IGG II 60 TESTS - 30221
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR 
MDR Report Key9924428
MDR Text Key207754978
Report Number8020790-2020-00040
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/10/2020
Device Catalogue Number30221
Device Lot Number1007673260
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/13/2020
Initial Date FDA Received04/03/2020
Supplement Dates Manufacturer Received05/29/2020
Supplement Dates FDA Received06/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-